Impact of Metabolic Syndrome on Development of Contrast‐Induced Nephropathy After Elective Percutaneous Coronary Intervention Among Nondiabetic Patients
ConclusionsMetabolic syndrome is a risk factor for CIN in patients with stable coronary artery disease who undergo elective PCI. We suggest that clinicians recognize the patients with MetS before elective coronary interventions.
Source: Clinical Cardiology - Category: Cardiology Authors: Ozgur Ulas Ozcan, Hacer Adanir Er, Sadi Gulec, Elif Ezgi Ustun, Demet Menekse Gerede, Huseyin Goksuluk, Cansin Tulunay Kaya, Cetin Erol Tags: Clinical Investigation Source Type: research
More News: Angioplasty | Cardiology | Cholesterol | Coronary Angioplasty | Heart | Men | Metabolic Syndrome | Percutaneous Coronary Intervention | Statin Therapy | Urology & Nephrology